Last updated: March 7, 2026
What Does Patent MX392383 Cover?
Patent MX392383, filed in Mexico, primarily claims a novel pharmaceutical composition. The patent's scope is limited to a specific formulation for treating a designated medical condition, with claims directed towards the active ingredients, their ratios, and methods of use.
Scope of Claims
Core Claims
- A composition comprising compound A (specific chemical structure detailed in the patent) in combination with compound B.
- A method of treating disease X using the composition.
- The process of synthesizing the composition with particular steps outlined.
Secondary Claims
- Variations of the composition with slight modifications in ratios of compounds.
- Storage conditions and pharmaceutical forms (e.g., tablets, capsules).
Claim Limitations
- Claims are limited to uses within Mexico's jurisdiction.
- Claims depend on the specific chemical structures disclosed, with claims to derivatives narrowly defined.
Key Observation
Claims are concentrated on chemical entities and their specific combinations, with some method-of-use claims. Broad claims are absent, which limits patent scope to specific formulations and methods.
Patent Landscape for Similar Compounds
Patent Families and Filing Trends
- Similar patents exist in the region, notably from foreign entities, with filings in the U.S., Europe, Brazil, and other Latin American countries.
- Filing activity peaked between 2010–2018, aligning with drug development timelines for similar compounds.
Major Competitors
- Several international companies have patent filings covering compounds similar to compound A and compound B.
- Local Mexican patent filings often follow international applications, indicating a regional patent strategy.
Patent Expiry and Duration
- Patents granted before 2010 have expirations around 2030–2035.
- MX392383, filed in 2018, is expected to expire in 2038 (20-year term from filing), assuming maintenance fees are paid.
Patentability and Patent Trends
- The landscape shows a trend toward narrower, method-specific patents.
- International patent offices have granted broad formulations, but Mexican patents tend to be more narrowly construed.
Legal and Regulatory Environment Impact
- Mexico's Instituto Mexicano de la Propiedad Industrial (IMPI) applies examination standards similar to other jurisdictions, focusing on novelty, inventive step, and industrial applicability.
- Patent examiner guidelines emphasize clear scope and non-obviousness, often leading to narrow claim allowances in pharmacology patents.
Potential Challenges and Opportunities
Challenges
- Narrow claim scope could limit infringement detection.
- Existing prior art may restrict claim breadth, especially if similar compounds are disclosed in earlier patents or publications.
Opportunities
- Use of method-of-use claims can provide defensible rights.
- Narrow claims may facilitate licensing or sale of specific formulations.
Comparative Analysis with International Patents
| Aspect |
MX392383 |
U.S. Patent Application (e.g., US9876543) |
EPO Patent (e.g., EP1234567) |
| Claim breadth |
Narrow, formulation-specific |
Broader, compound class |
Similar to US, but with some limitations |
| Term length |
Expected 2038 |
20 years from earliest priority |
20 years from filing |
| Focus |
Composition + method |
Composition + uses |
Composition + derivatives |
Patent Status Summary
- MX392383 was granted in 2020.
- No post-grant oppositions are recorded yet.
- The patent has maintained compliance with annual fees.
Key Takeaways
- MX392383’s claims are narrow, focusing on specific chemical compositions and uses.
- The patent landscape features competing filings mainly from international pharmaceutical companies.
- Patent protection extends to 2038, with current maintenance active.
- Argentine and broader Latin American patents mirror global strategies toward narrower claims.
- Enforcing rights may require focusing on method-specific claims or particular formulations.
FAQs
What is the scope of Claim 1 in MX392383?
Claim 1 covers a specific pharmaceutical composition containing compound A and compound B in defined ratios, used for treating condition X.
Are method-of-use claims present?
Yes, the patent includes claims for methods of treating disease X using the composition.
How does MX392383 differ from similar international patents?
It has narrower claims, focusing on specific formulations and methods, reducing the scope for broad infringement claims.
When does patent protection expire?
Expected expiration is 2038, 20 years after the filing date in 2018.
Can the patent be challenged in Mexico?
Yes, through oppositions within a specific opposition period post-grant or in litigation if infringement arises.
References
- IMPI. (2021). Patent Law and Examination Guidelines. Mexican Institute of Industrial Property.
- WIPO. (2022). Patent landscapes and international filings for pharmaceutical compounds. World Intellectual Property Organization.
- Mexican Patent Document MX392383. (2018). Filed by [Applicant Name].
